Korea Lifescience Resource Guidebook2009

KOREA,
The Gateway to ASIA
KOREA Life Science Services

Resource Guide
2009
Contract Research
Contract Manufacturing
Contract Development
KOREA,
The Gateway to ASIA
KOREA Life Science Services

Resource Guide
2009
Contract Research
Contract Manufacturing
Contract Development
Contents
5
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
KOREA Life Science Services Resource Guide 2009
Korea Biotechnology Industry Organization

AJOU UNIVERSITY MEDICAL CENTER Regional Clinical Center
AMC CRC (ASAN Medical Center Clinical Research Center)
AnC Bio, Inc.
Amicogen, Inc.
BEAMS BIOTECHNOLOGY CO., LTD.
Biotoxtech Co.,Ltd.
BIOTRION Co., Ltd.
C&R Research Inc.
Chemizon - A division of Optomagic Co., Ltd.
Chemon co.,Ltd
Chonbuk National University Hospital Clinical Trial Center (CNUH CTC)
Chonnam National University Hospital Clinical Trial Center
Chungnam National University Hospital Clinical Trials Center
Clinical Trials Center, Seoul National University Hospital
CMC Clinical Research Coordinating Center
DNA Link, Inc.
Dong-A University Hospital Clinical Research Center
DramCIS Inc.
GENOMINE, INC.
Hubertbio
INHA University Hospital Clinical Trial Center
Inje University BusanPaik Hospital Clinical Trial Center
Inje University Pharmaco Genomics Research Center
Korea Institute of Toxicology
Korea National Enterprise for Clinical Trials.
KOREASTEVIA CO.,LTD
Korea Testing and Research Institute
Korea University Anam Hospital Clinical Trial Center
Kyungpook National University Hospital Clinical Trial Center
LSK Global Pharma Services Co., Ltd
Medi Kinetics Co., Ltd.
PharmaCRO
Qu-BEST Consulting Co., Ltd.
Samsung Medical Center Clinical Trial Center
Seoul Clinical Laboratories(SCL), Central laboratory Services
Seoul Pharma Laboratories, Inc.
Solomon Medical Research, Inc.
World Courier Korea Co.,Ltd
YeBT
Yonsei University Health System Clinical Trials Center
Young In Frontier Co., Ltd.
About koreaBio
koreaBio is a non-profit organization representing Korea Biotechnology
Industry. Our association was formed as a result of merge between
three different industry associations in biotechnology field November
2008. Our missions are to become a supportive organization to serve
the member companies more efficiently and a reliable partner of
the government. Also we actively participate as a member of the
international bio-industry communities and to develop various
training and policy making programs to support the industry and
government. Our members are over 250 companies as of Jun. 2009.
koreaBio Services
Industry development and support
koreaBio has been planning and managing biotechnology R&D
projects and development projects. Also we are supporting
biotechnology incubation such as establishment and operation of the
biotechnology transfer center, joint IR for IPO of biotech companies.
International cooperation
koreaBio supports a participation in international exhibition and
partnering meetings to provide opportunities to expand a business
the worldwide. Also koreaBio hosts Road-shows to introduce Korea
Biotechnology products and technologies.
Information support and public relations

koreaBio publishes Koreas biotechnology statistics and electronic
newsletter to approximately 12,000 subscribers.
For further information, please visit www.koreabio.org.
company name
AJOU UNIVERSITY MEDICAL

CENTER Regional Clinical Center
company profile
Welcome to the Clinical Trial Center(CTC) of Ajou University
Hospital. Established in 1994, the CTC has consistently aimed
through countless multi-center trials to provide researchers in the
public and private sectors with optimal research environments that
enable ethical, scientific and systematic clinical investigations.
Education
koreaBio operates national educational programs for biotechnology
development to professionals and scientists and engineers in
Bio-industry.
business category
contract research
contract manufacturing
contract development
clinical research
support services
non clinical
formulation development
organization
address 9F., Unik Bldg, 706-13, Yeoksam-Dong, Kangnam-Gu Seoul, Republic

of Korea135-918
Sector
Non-profit organization Trade association
website
http://www.koreabio.org
Contact1 InSuk(Lydia) Son, Assistant Manager

tel
+82-70-8610-3537
e-mail insuk@koreabio.org
address San 5, Wonchun-dong, Yeongtong-gu, Suwon, Korea 443-721

website
http://rctc.ajoumc.or.kr
tel
+82-31-219-4469
fax +82-31-219-4265
contact
Lim Sewom
Contact2 JongHoon Choi, Executive Director
e-mail
ajourctc@ajou.ac.kr
start-up year 2005
tel
CEO
Park, Hae-Sim
employees 30
+82-70-8610-3533
e-mail jchoi@koreabio.org
company name
AMC CRC (ASAN Medical Center Clinical
company name
AnC Bio, Inc.
Research Center)
company profile
company profile
AnC Bio has established most advanced and massive cell culturing
facilities that include 30 cleanrooms. The company has made it
facilities complying with the world leading GMP standards.
AnC Bio has exclusive manufacturing and distribution rights for
MyoCell that is a novel cell therapy for CHF patients. The company
has rich resources to meet various needs of the contract-givers for
cell-based products.
The AMC CRC is a top organization that makes patients and

sponsors satisfied, and committed to clinical trial investigators for
development of innovative medical treatment. We are pursuing
cooperation and creativeness based on cutting-edge technology
and qualified system assured by Global QA Director.
business category
contract research
clinical research
support services
non clinical
organization
contract research
clinical research
support services
non clinical
organization
address 86, Asanbyeongwon-gil, Songpa-gu, Seoul 138-736 Korea
address H.Q: 884-1 Eyon-ri, Cheongbuk-myon, Pyeongtaek, Gyeonggi, Korea

Seoul Office: H&S Tower 10th Fl., 119-2 Nonhyun-dong, Ganganam-gu,
Seoul, Korea
website
http://crc.amc.seoul.kr/
website
www.ancbio.com
tel
+86-2-3010-7368
tel
H.Q: +82-(0)31-686-9450
Seoul Office: +82-(0)2-549-7088
contact
Ha-Yeong Koo
fax
H.Q: +82-(0)31-686-9451
Seoul Office: +82-(0)2-549-7044
e-mail
hykoo@amc.seoul.kr
contact
Sean Choi / Senior Manager / Medical Team
CEO
Jung-Shin Lee(Executive Director: Dongho Lee)
e-mail
sdchoi@ancbio.com
start-up year 1999
CEO
Jong-Weon Choi
employees 45
employees 6,781
business category
fax +86-2-3010-7171
start-up year 2002
company name
Amicogen, Inc.
company profile
company name
company profile
Our company has world-wide competitiveness in the development

of specialty enzymes (proteins) by unique directed molecular
evolution and enzyme engineering technologies. We also have good
experiences and facilities (GMP) for the production of enzymebased fine chemicals.
BEAMS Biotechnology is one of the contract manufacturers for

plasmid DNA and recombinant Protein produced by microbial
fermentation. With an innovative and proprietary process design,
we provide strictly quality-driven pDNAs or proteins with lot sizes
from 10 milligram upto kg scale.
We manufacture all kinds of pure plasmid DNA and recombinant
Protein purified from microbial cultures. Also, we provide contract
development service for scale-up and improvement of
manufacturing process, documentation service of BPR for nonclinical test, and consulting service of manufacturing sample for
clinical application including the technology transfer of
manufacturing process to cGMP facility.
business category
10
BEAMS BIOTECHNOLOGY CO., LTD.
contract research
clinical research
support services
non clinical
organization
business category
contract research
clinical research
support services
non clinical
organization
address 694-4 Sangchon, Jinsung, Jinju 660-852, South Korea
address B104 SuntechCity II, #307-2 Joongwon-ku, Sungnam, Kyoungki-Do,

Korea 462-736
website
http://www.amicogen.com/english
website
http://www.beamsbio.co.kr
tel
+82-55-759-6161
tel
+82-31-737-4970
contact
CHEOL KIM, President / DOYUN KIM, Director
fax +82-55-759-6094
fax +82-31-737-4972
contact
Dr. Yong Chul Shin
e-mail
ycshin@amicogen.com
start-up year 2000
e-mail
beamsbio@naver.com
start-up year 2006
CEO
Dr. Yong Chul Shin
employees 30
CEO
CHEOL KIM
employees 7
11
company name
Biotoxtech Co.,Ltd.
company profile
company name
BIOTRION Co., Ltd.
company profile
Biotoxtech is a life science company and a Contract Research

Organization(CRO) that primarily conducts compliance studies for
product safety.
Headquartered in Ochang, Korea, biotoxtech owns and operates a
146,300 sq. ft. facility. With 10 years of industry experience,
Biotoxtech conducts compliance safety testing and research
following Good Laboratory Practices (GLP).
BIOTRION is organized with experts who have more than 10 years

of experiences and successfully commercialized various
biopharmaceutical products.
BIOTRION provides CONSULTING(product/business development
and registration), CRO(CMC/pre-clinical study design and study
monitoring) and LICENSING(technology & product license-IN and
OUT) Services.
We do our best, putting ourself in clients place, to acquire the
biggest achievement by optimizing strategy for product and
business development and participation in whole development
process.
business category
12
contract research
clinical research
support services
non clinical
organization
business category
contract research
clinical research
support services
non clinical
organization
address Ochang science industrial complex, 686-2 Yangcheong-ri, Ochang-eup,

Cheongwon-gun, Chungbuk province, 363-883 Korea
address BIOTRION Co., Ltd. F2, KAST B/D, 7-1, Gumi-Dong, Bundang-Gu,
Seongnam-Si, Gyeonggi-Do, Korea
website
http://www.biotoxtech.com
website
http://www.biotrion.com
tel
+82-43-210-7788
tel
+82-70-7508-2340 ~ 2353
contact
Marketing Team
contact
Hyosil Lee
e-mail
mgt177@biotoxtech.com
start-up year 2000
e-mail
hslee@biotrion.com
start-up year 1999
CEO
Jong-Koo Kang
employees 150
CEO
David Song
employees 16
fax +82-43-210-7789
fax +82-31-726-3978
13
company name
C&R Research Inc.
company name
Chemizon - A division of
Optomagic Co., Ltd.
company profile
C&R Research, the first CRO in Korea established in 1997 and
awarded the Korean CRO of the Year 2008 from Frost & Sullivan,
has seen phenomenal growth since its foundation, with highly
qualified staff with international and domestic experience over 300
clinical trials from around 80 customers in the pharmaceutical.
biotech and medical device industries. We work to ensure our
clients meet their project obligations in a timely manner and within
established quality standards. Our large footprint and strong
relationships allows to rapidly initiate, manage and deliver research
results. Particular experiences and expertise can be offered in the
following indications: Oncology, Cell therapy, Gastroenterology,
Endocrinology, Cardiovascular Urology, Nephrology, Gynecology,
Dermatology, Antiallergics, Neurology
Immunology, Device, Anti-infectives, Psychiatry, Respiratory
Chemizon is a collaborative drug discovery services organization

with operations in South Korea, China and the United States. Our
goal is to become the partner of choice for Pharmaceutical and
Biotech companies around the globe, that seek to cost effectively
enhance their internal pipelines. Our experienced, repatriated
management team and skilled scientists leverage a fully integrated
platform that includes medicinal chemistry, computational
chemistry/structural biology, discovery biology, ADME/DMPK and
pharmacology, to help our partners discover novel small molecules
in the disease areas of oncology, metabolic disorders and CNS. For
more information on Chemizon, please visit our web site at
www.chemizon.com.
business category
business category
14
company profile
contract research
clinical research
support services
non clinical
organization
contract research
clinical research
support services
non clinical
organization
address 2/FI, Yiyangwon BD, 63-7 Gyeongun-dong, Jongno-gu, Seoul 110-310

Korea
address 3F 333-1, Sangdaewon-Dong, Jungwon-Gu, Seongnam-Si, GyeonggiDo, KOREA, 462-807
website
www.cnrres.co.kr
website
www.chemizon.com
tel
+82(0)2 6251 1500~3
tel
+82-31-777-7800
contact
ByungIn Yoon
contact
Seoyoung Yang
e-mail
biyoon@cnrres.co.kr
start-up year 1997
e-mail
syyang@chemizon.com
start-up year 2005
CEO
MoonTae Yoon
employees
CEO
Anthony D. Piscopio
employees 200
fax +82(0)2 6251 1504
fax +82-31-777-7898
15
Chemon co.,Ltd
company name
company name
Chonbuk National University Hospital

Clinical Trial Center (CNUH CTC)
company profile
Chemon is the first established GLP CRO company that secured compatible
abilities along with research staffs in Korea. Chemons GLP system has
been certified by KFDA, NIER and RDA. With many experts in diverse fields,
we now are engaged in the test and analysis of drug effect along with toxicity
test. In cooperation with business partners, we provide distinctive and onestop service including clinical research, agency work for diverse approvals,
development and commercialization of new compounds, and so on.
Chemon management and research team has developed strong position in
the field of toxicity, efficacy, BE test, in-vivo pharmacological screening, etc.
Toxicity test -General toxicity, Reproductive toxicity, Genetic toxicity,
Antigenicity, Local toxicity, Carcinogenicity, etc.
Efficacy test -Anti-cancer, Diabetes, Arthritis, Gastric Ulcer, Hair Growth,
Liver Function, Osteoprosis, Obesity, Dementia, Immunity
company profile
With our Clinical Trial Center as your partner, there are potential
benefits, which are the evidence-based clinical trial design for
innovative discoveries. We offer a full array of services in all Phases
studies on innovative discoveries. With these services, we can support
you at every step along your studys path to help you make the new
medicines that let us live longer and stay healthier than ever before.
Yet beyond our extensive expertise, our time-proven processes, and
our highly trained staff, we offer another advantage others cannot-the
commitment to intelligently apply our collective resources to ensure
that your study progresses quickly, seamlessly, and successfully. In
addition, our proven strategies and techniques will not only help you to
recruit participants. No other research organization equals our
knowledge, our capacity, or our commitment to your success. Well
also save you a significant amount of time and money.
business category
contract research
clinical research
support services
non clinical
organization
business category
address Gyeonggi Bio Research Center (Headquarter) 11F, Gyeonggi Bio

Center,864-1, Iui-Dong, Yeongtong-Gu, Suwon-Si, Gyeonggi-Do, S.Korea
Yangji Preclinical Research Center 334,Jeil-Ri, Yangji-Myeon,CheoinGu, Yongin-Si, Gyeonggi-Do, S.Korea
16
contract research
clinical research
support services
non clinical
organization
address 634-18, Geumam-dong, Deokjin-gu, Jeonju, 561-712, Republic of Korea
website
www.chemon.co.kr
tel
Gyeonggi Bio
Research Center
+82-31-888-6633~6
Yangji Preclinical
Research Center
+82-31-329-9900
website
http://www.jbctc.co.kr
fax
Gyeonggi Bio
Research Center
+82-31-888-6640
Yangji Preclinical
Research Center
+82-31-329-9901
tel
+82-63-250-2345
contact
+82-31-888-6634
contact
Ji-Young Jeon, Pharmacist
e-mail
hmj511@chemon.co.kr
start-up year 2000
e-mail
jjy@ctcf2.com
start-up year 2005
CEO
Cheolseung Peck
employees 80
CEO
Soo-Wan Chae, M.D.,Ph.D.
employees 32
fax +82-63-250-2349
17
company name
Chonnam National University

Hospital Clinical Trial Center
company profile
company name
company profile
CNUH CTC implements ethical and scientific clinical trials in

accordance with the guidelines of ICH-GCP and KGCP, and
supports clinical research activities by providing the best
environment. Researchers at Chonnam National University
Hospital have been playing a leading role in conducting ethical and
scientific clinical trials based on the spirit of respect for life that
has been honored for the past 100 years, as well as their diverse
educational background and experience in the field of clinical
research.
Chungnam National University Hospital Clinical Trials

Center(CNUH CTC) was established in January 2008 to implement
effective clinical trials. We will provide a resource and assistance
for investigators and their staffs. Our mission is dedicated to
enhance ethical and professional service in clinical trails,
ultimately, this will contribute to human happiness.
business category
business category
18
Chungnam National University

Hospital Clinical Trials Center
contract research
clinical research
support services
non clinical
organization
contract research
clinical research
support services
non clinical
organization
address 671 Jebongno, Donggu, Gwangju, Korea (501-757)
address 33 Munhwa-ro, Jung-gu, Daejeon, 301-721, Korea
website
http://www.cnuhctc.com
website
www.cnuh.co.kr/ctc/
tel
+82-62-220-5231~2
tel
+82-42-280-8700~1
contact
Geun-seong Lim
contact
Sun-Kyung Jung
e-mail
ctc@cnuh.com
start-up year 2002
e-mail
cnuhctc@cnuh.co.kr
start-up year 2008
CEO
Jin-Sang Yoon
employees 25
CEO
Won-Hyung Lee
employees 16
fax +82-62-225-9400
fax +82-42-280-8726
19
company name
Clinical Trials Center, Seoul

National University Hospital
company profile
company name
CMC Clinical Research

Coordinating Center
company profile
Welcome to Clinical Research Coordinating center of Catholic Medical
Center[CMC CRCC] !
The mission of CMC CRCC is to provide an outstanding environment
that will help CMC investigators conduct clinical researches of the
highest quality that are safe, efficient, and ethical through cooperation
with industry, academia and other research institutions.
The CMC CRCC operates to foster multi-institutional clinical research
through the development, management, and reporting of clinical trials
as a coordinating center for the CMC affiliated general hospitals. Clinical
research related services provided by CMC CRCC are as follows:
* Study design, development, implementation and enforcement of the
study protocol and manual of operations
* Pharmacokinetics and pharmacodynamics modeling & simulation
* Project management, data and safety monitoring, and quality assurance
* statistical analysis and interpretation and dissemination of results
* Education and training for clinical research investigators and coordinators
Clinical Trials Center, Seoul National University Hospital, was

established in 1995 and has supported many clinical trials. With
excellent clinical researchers and research capabilities, CTC is
continously enhancing ethical and scientific achievements in
clinical research and implementing efficient clinical trial systems
by providing a state-of-the-art research environment.
business category
contract research
clinical research
support services
non clinical
organization
business category
20
contract research
clinical research
support services
non clinical
organization
address 101 Daehak-Ro, Jongno-Gu, Seoul, 110-744, Korea
address 505 Banpo-Dong, Seocho-Gu, 137-701, Seoul, Korea
website
http://ctc.snuh.org
website
http://cmccrcc.catholic.ac.kr
tel
82-2-2072-1675
tel
82-2-2258-7854
contact
Mr.Hyung-Rak Song
contact
Eunkyong, Cheong
e-mail
hyra@snuh.org
start-up year 1995
e-mail
crcc@catholic.ac.kr
start-up year 2004
CEO
Dr.Kyung-Up Min
employees 33
CEO
Kim. Kyung Soo
employees 10
fax 82-2-3675-8334
fax 82-2-2258-7859
21
company name
DNA Link, Inc.
company name
Dong-A University Hospital

Clinical Research Center
company profile
DNA Link, Inc. is the Total Solution Provider of Genomic Research,
from consulting project to statistic anlysis of huge data. We have
retained most updated platform, skillful technicians with over 10
year experience and best bioinformaticians.
DNA Link, Inc. has certified ISO9001 and approved as the Certified
service provider of Affymetrix, Agilent, RocheNimbleGen based on
the high quality performance.
Our Clinical Research Center gained approval of the Phase1

Clinical Medical Center in 2003, which built infrastructure in
accordance with GCP principle, put forth our whole energy to
support clinical research affairs in Busan, especially, we are
established through cerebro-cardiac vascular disease related
clinical research.
business category
business category
22
company profile
contract research
contract research
clinical research
clinical research
support services
non clinical
support services
non clinical
organization
organization
address 3rd Fl, VICHEN CITY Bldg. Sungsan-dong 591-4, Mapo-gu, Seoul, Korea
(121-850)
address 3-1Ga, Dongdaeshin-dong, Seo-gu, Busan 602-714, Korea
website
www.dnalink.com
website
none
tel
+82-2-3153-1500
tel
+(82-51) 240-2611
contact
Sujin Kim
contact
YunYoung, Heo
e-mail
office@dnalink.com
start-up year 2000
e-mail
yunza@damc.or.kr
start-up year 2004
CEO
Jong-eun Lee, Ph.D.
employees 29
CEO
MooHyun, Kim
employees 14
fax +82-2-364-4778
fax + (82-51) 257-2616
23
company name
DramCIS Inc.
company name
company profile
company profile
DreamCIS is a full service contract research organization(CRO) that

offers services to the pharmaceutical companies, bioventures,
medical device manufacturers and functional food producers.
DreamCIS provides clinical trial services for a broad and detailed
range of therapeutic area in accordance with the standard
operating procedures consistent with both Korean regulations and
global standards including ICH-GCP guidelines.
Our key service areas include clinical trials, PVPMS, QA audit, data
management and biostatistical analysis and health fucntional foods
trials.
Genomine has leading edge technology in discovering plant genes.

We strive for mining of essential and novel plant genes in a largescale and understanding of their function using plant functional
genomics and proteomics approach.
We have been successful in identifying the regulatory genes of
higher plants involved in the circadian rhythms, yield increment,
dwarfism and salt tolerance.
And we are also working on Products & Services as follows.
1) Plant transformation and Herbicide screening system
2) Proteomic Services(2DE, MS, Phospho protein analysis,
Glycoprotein analysis)
3) Phospho Protein enrichment Kit
4) Phospho Peptide enrichment Kit
business category
24
GENOMINE, INC.
contract research
clinical research
support services
non clinical
organization
business category
contract research
clinical research
support services
non clinical
organization
address 1010 Jeokseon-Hyundai Building, 80 Jeokseon-dong, Jongno-gu, Seoul
address Venture Bldg. 306 Pohang TechnoPark Pohang, Kyungbuk, 790-834, Korea
website
http://www.dreamcis.com/new/eng/main/main.php
website
www.genomine.com
tel
+82-2-2010-4500
tel
+82-54-223-2461
contact
Joon-Young Lee
contact
Yong Suk Joh
e-mail
dreamcis@dreamcis.com
start-up year 2000
e-mail
ysjoh@genomine.com
start-up year 1999
CEO
Won-Jung Choi
employees 110
CEO
Kyung-Mok Park
employees 13
fax +82-2-2010-4593
fax +82-54-223-2460
25
company name
Hubertbio
company name
INHA University
company profile
Hubertbio is a leading CROs in Korea, mainly forcused on bioequivalence
study in human. We perforrm all of the procedures in compliance with
the Bioequivalence Test Guideline(No. 2008-22 of the KFDA).
Bioequivalence study means an in vivo study to verify the statistical
equivalence in bioavailability between two drugs with the same
active ingredient and route of administration that are absorbed into
the systemic circulation and became available at the site of action.
We can provide a practiced and professional consultation about drug
development procedures in especially bioequivalence study. That is
because we have lots of experiences and specialists in related fields,
latest equipments and partnership with trustworthy institutions.
But most of all, we always move toward win-win situation.
We ensure that we will be your trusty companion.
For more informations, please visit our website www.hubertbio.com.
company profile
INHA-CTC was designated for Regional Clinical Trial Center by the
Korean Ministry for Health, Welfare and Family Affairs in 2008.
By building up the advanced and specialized infrastructure, INHACTC will be one of the major Clinical Trial Centers with international
competitiveness. We will make our efforts to accomplish the
business model to create added values.
business category
business category
26
contract research
clinical research
support services
non clinical
organization
contract research
clinical research
support services
non clinical
organization
address Kyung-hee Clinical Trial Center, Kyung-hee Univ. Medical Center,

Hoegi-dong Dongdaemun-gu, Seoul, KOREA
address Jeongseok Bldg. 7-241 Shinheung-dong 3ga Jung-gu, Incheon ,400712 Korea
website
www.hubertbio.com
website
http://www.inhactc.com
tel
+82-2-966-1120
tel
+82-32-890-1103
contact
Ju Hee, Kim
contact
Kim Eun Gyung
e-mail
hubertbio@hubertbio.com
start-up year 2007
e-mail
keun14@inha.com
start-up year 2008
CEO
Il Su, Yuk
employees 12
CEO
Nam moon suk
employees 25
fax +82-2-966-1132
fax +82-32-890-1120
27
company name
Inje University BusanPaik

company profile
company name
company profile
The highest recognized, experienced clinical trial center in the

South East Region of Korea(Busan, Kyungnam province) with
8million population, the center provides all phase trials sponsored
or investigator initiated which was supported by state of the art
facilities, experienced staff, global accredited IRB, and high top
Core laboratory processing system.
business category
28
Inje University Pharmaco

Genomics Research Center
PGRC is highly recognized as a top frontier research institute in the

field of PGx and personalized pharmacotherapy worldwide. PGRC
Researchers are currently involved in various projects funded by
government and pharmaceutical industries, covering drug
metabolism and transport, personalized medicine, genotyping chip
development, drug interactions, and biomarker discovery.
business category
contract research
contract research
clinical research
clinical research
support services
non clinical
support services
non clinical
organization
organization
address BusanPaik Hospital, Gaegeum-dong, BusanJin-gu, Busan City, 614735 South Korea
address Inje University College of Medicine, Gaegeum2-dong, BusanJin-gu,

Busan City, 614-735 South Korea
website
www.paikctc.ac.kr
website
http://pgrc.inje.ac.kr
tel
+82-51-890-6436~7
fax +82-58-891-6438
tel
+82-51-890-6415
contact
Eunyoung Yu / Inhe Hwang
start-up year 1996
contact
Seok-Ki Lee
e-mail
eunoyu@busanpaik.ac.kr / rokmc806@busanpaik.ac.kr
e-mail
pgrc@inje.ac.kr
start-up year 2003
CEO
Director: Jae-Gook Shin, MD, PhD
CEO
Director: Jae-Gook Shin, M.D., Ph.D.
employees 60
employees 63
fax +82-51-893-1232
29
company name
Korea Institute of Toxicology
company name
Korea National Enterprise

for Clinical Trials.
company profile
Korea Institute of Toxicology (KIT) is a world-class prestigious nonclinical contract research organization. We perform non-human
primates toxicology test as well as carcinogenicity, reproductive
toxicology test in accordance with FDA, OECD guidelines. Second
Campus in Jeongeup will be constructed at 2010.
company profile
Korea National Enterprise for Clinical Trials is the organization
endorsed by the Ministry of Health Welfare and Family Affairs and
in collaboration with the Korea Food and Drug Administration to
build up clinical trials infrastructure. KoNECT supervises and
coordinates a network of 14 Regional Clinical Trial Centers;
develops and operates training programs for trial specialists and
supports and guides new development of technology in an effort to
maximize impact and dynamize synergy among infrastructure,
human resources, and technology.
Korea, the hub of global clinical trials. KoNECT, a global contributor
to world healthcare.
business category
30
contract research
clinical research
contract research
support services
non clinical
clinical research
organization
support services
non clinical
organization
business category
address P.O. Box123, 19 Shinseongro, Yuseong, Daejeon, 305-600, KOREA
address 101 Daehakno, Chongno-gu,Seoul 110-799, Korea
website
www.kitox.re.kr
website
www.konect.or.kr
tel
+82-42-610-8105
tel
+82-2-3668-7609
contact
Vince Rubino(vince@kitox.re.kr)
contact
Ms Min Young KIM, External Affairs Manager
e-mail
webmaster@kitox.re.kr
start-up year 2002
e-mail
minyoungkim@snu.ac.kr
start-up year 2007
CEO
Myung-Sang Kwon
employees 240
CEO
Sang Goo Shin
employees 10
fax +82-42-610-8085
fax +82-2-3675-4777
31
company name
KOREASTEVIA CO.,LTD
company profile
company name
company profile
Koreastevia Co.,Ltd is using stevia which is herbal plant that have

high sugar content, low-calorie, antioxidation that have an unique
special permission manufacture technology.
Also, various effect receives proof and produce and export organic
resources, feedstuff, food and sugar principal parts sweetening
materials, cosmetics, medicine raw material etc. is bio-venture
business.
Spur more in current R&D will become international enterprise
which is The good company which responsibility exists to nature
and mankind after 30 years
Throughout testing, certifying, technology consulting and

researching, KTR helps industries ranging from chemicals,
pharmaceuticals, metalworking, automotive to shipbuilding.
KTR, as a certified GLP inspection institute with qualified experts, is
capable of simultaneously operating assessment and analysis on
preclinical trials, efficacy testing, environmental toxicology testing
and medical device evaluation under GLP quidelines of which
standard is acknowledged by OECD member countries
corresponding to the Safety inspection Data of EUs REACH and
GHS.
KTR promises to advance one and alls future with greater security
and extra comfort founded upon its high-precision technology,
ceaseless endeavor and solid loyalty.
business category
32
Korea Testing and Research Institute
contract research
clinical research
support services
non clinical
organization
business category
contract research
clinical research
support services
non clinical
organization
address 538-12, jeopji-ri, lbam-myeon, jeongup-si, jeollabuk-do, korea
address 88-2, Yeongdeungpo-dong 8 ga, Yeongdeungpo-gu, Seoul, 150-038

Republic of Korea
website
www.koreastevia.com
website
www.KTR.or.kr
tel
+82-63-534-0333
tel
+82 (0) 2-2164-0023~4
contact
JEONG ILL HWAN
contact
Chung-hyup Lee, Yousun Ha
e-mail
stevia21@korea.com
start-up year 2001
e-mail
yichy@ktr.or.kr, and celestiar@ktr.or.kr
start-up year 1969
CEO
JEONG ILL HWAN
employees 50
CEO
Kisung Cho, President
employees 350~400
fax +82-63-534-0222
fax +82 (0) 2-2634-0016
33
company name
Korea University Anam Hospital

Clinical Trial Center
company profile
company name
Kyungpook National University

company profile
Korea University Anam Hospital is one of the largest medical

centers in Korea, which has 950 beds.
Korea University Anam Hospital Clinical Trial Center has been
operated from September, 2003.
The goal of Korea University Anam Hospital Clinical Trial Center is
to establish the CTC as a role of supervision, research and
education, and to be specialized for the late clinical trials of
environmental and metabolic diseases and early clinical trials of
hematologic and circulatory diseases.
Kyungpook National University Hospital Clinical Trial Center(KNUH CTC) was

established as a regional clinical trial center and certified by The Ministry of Health and
Welfare, Korea in 2005. Since its inception, our center has offered a wide range of
services for Phase I~IV Clinical trials. KNUH CTC is a complete service clinical trial
facility with 32 full-size research beds equipped with central monitoring unit, lounge
for subjects and GLP-compliant bioanalytical laboratories. KNUH CTC provides a
specialized service for pharmaceutical product development and clinical management
for domestic and global I~IV clinical trials. For the state of the art clinical trials, we are
staffed with highly trained and dedicated professional research personnel. Our
research team provides operational excellence through timely and precise clinical
data which will help you make effective decisions about the safety and efficacy of your
compound. All clinical trials are performed by ICH-GCP and Korean GCP guidelines.
business category
contract research
clinical research
support services
non clinical
organization
business category
contract research
clinical research
support services
non clinical
organization
address 200 Dongduk-Ro, Jung-gu, Daegu, 700-721, Korea
34
address 126-1, Anam-Dong, 5-Ga, Seongguk-Gu, Seoul 136-705
website
http://ctc.knu.ac.kr
website
http://ctc.kumc.or.kr
tel
+82-53-420-6355,6(Adm Office) / +82-53-420-6941~7(CRU)
tel
+82 2 920-6566 / 6466
fax +82 2 920- 6465
contact
Young Hye, Kim
start-up year 2003
contact
Jong Ha Kim
e-mail
irbadmin@kumc.or.kr
employees 14
e-mail
ctc@knu.ac.kr
start-up year 2005
CEO
In, Kwang Ho Director of Clinical Trial Center
CEO
Sung Kyoo Hwang
employees 34
+82-53-420-5443(LAB)
fax +82-53-420-5218
35
company name
LSK Global Pharma

Services Co., Ltd
company name
Medi Kinetics Co., Ltd.
company profile
company profile
Leading Clinical Trials in Korea
LSK Global Pharma Services Co., Ltd((LSK in short) originates from WestatKorea, a US corporate, which opened its Korean branch on March 2,
2000.Stat-Korea was incorporated as a Korean corporate in 2001, and took
over the Korean branch of Westat-Korea. It changed its name to Lifecord StatKorea, after business merger with Lifecord, and changed its CI to LSK in 2007.
Since its establishment in 2000, LSK has been growing very rapidly. LSK has
been seeking clinical trial projects from global sponsors as well as working
with domestic sponsors doing clinical projects abroad from the beginning. It
has been audited numerous times for qualification by a number of global
CROs(Contract Research Organizations) and pharmaceutical companies. LSK
is globally recognized, and its trials meet the standard of US and European
regulatory agencies.
Non Clinical CRO service provider dealing with large sized animal
especially mini pigs. We provide PK, Medical Device Testing,
Toxicology and Pharmacology study service.
business category
contract research
clinical research
support services
non clinical
organization
business category
36
contract research
clinical research
support services
non clinical
organization
address Pyeonghwan Bldg. 5F. 6F, 1579-6 Seocho-dong, Seocho-gu, Seoul 137875 Korea
address 1026-1 Yulbuk, Chung buk, Pyoungtaik, Gyounggi, Korea
website
www.lskglobal.com
website
www.SPFPIG.com
tel
+82-2-546-1008
tel
+82-31-683-0643
contact
Oh, Kyu Ho / Business Development Director
contact
Michael Kim
e-mail
khoh@lskglobal.com
start-up year 2000
e-mail
mikekim@spfpig.com
start-up year 2000
CEO
Lee Young Jack
employees 75
CEO
Michael J. Kim
employees 30
fax +82-2-584-9008
fax +82-31-683-0647
37
company name
PharmaCRO
company name
company profile
company profile
Clinical trials are one of the most important parts of the drug development process
and also one of the most time-consuming processes. A Contract Research
Organization(CRO) is a service organization that provides support to the
pharmaceutical, nutraceutical, biotech industry. PharmaCRO is leading clinical
CROs in Korea that provide a full range of clinical development services and conduct
research in Asian countries and approximately 15 clinical trials are conducted in
Korea each year sponsored by both industry and government. The industry has
evolved from providing primarily clinical services or single- service support in clinical
monitoring and data management to a full-service industry offering services from
the earliest stages of development through clinical trials and commercialization of
products. We provide a wide range of clinical development services to research
sponsors, including consultation with study design, investigator recruitment, study
monitoring, data analysis, and IND/IRB/NDA documentation works. For more
details, please visit our website www.PharmaCRO.co.kr
Qu-BEST Consulting specializes in contract research, project

management and expert consultancy for the registration of NCEs,
biopharmaceuticals, functional food, agrochemicals, veterinary
medicine and industrial chemicals, and consist of specialists for
more than 10 years with specialized knowledge and related
industrial experiences. We basically collaborate in partnership with
our clients and is not your ordinary contract research organization.
We provide high quality outsourcing services with optimal
development plan, cost-effective and in compliance with
international guidelines.
business category
business category
38
Qu-BEST Consulting Co., Ltd.
contract research
clinical research
support services
non clinical
organization
contract research
clinical research
support services
non clinical
organization
address 1F, 152-1 Bundang-dong Bundang-gu, Seongnam-si,463-030, KOREA
address #603-1 B-dong, Bundang Technopark, 148 Yatap-dong, Bundang-gu,

Seongnam-si, Gyeonggi-do, 463-760, Korea
website
www.PharmaCRO.co.kr
website
http://www.qubest.co.kr
tel
+82-31-707-1139~40
tel
+82-31-706-2995
contact
James Kim
contact
Jonghwa Go (General manager)
e-mail
nskim@PharmaCRO.co.kr
start-up year 2008
e-mail
jhgo@qubest.co.kr
start-up year 2008
CEO
James Kim
employees 7
CEO
Soohyeon Kim
employees 3
fax +82-31-707-1180
fax +82-31-706-2996
39
company name
Samsung Medical Center

Clinical Trial Center
company profile
company name
Seoul Clinical Laboratories(SCL),

Central laboratory Services
company profile
The Samsung Medical Center Clinical Trial Center was established

in Jan. 1999 to support the development of clinical research by
providing optimum research environment which enables
systematic accomplishment of research activities. As the Principle
Investigator friendly Core Center, our center will continuously strive
to strive to be equipped with optimum clinical research environment
to provide customized research support.
SCL has led the medical diagnostic industry for 26 years with its
fundamental values of Service, Quality and Research. SCL,
thereafter, established in 1983 as the pioneer reference laboratory
was a first company here to be named as an officially CAP
accredited facilities in 1997 in Korea. We started central laboratory
services, a part of CRO business, from 2005 based on wide
experiences in laboratory medicine field. Further, we contracted
service agreement with MCM clinical trial division of Mitsubishi
Chemical for asia-pacific global market. SCL C-lab will further
expand its CRO business to fulfill the unmet needs of the
pharmaceutical industry.
business category
contract research
clinical research
support services
non clinical
organization
business category
contract research
clinical research
support services
non clinical
organization
address Central Lab.; 5F, Venture Bldg., 76-6, Hannam-dong, Yongsan-gu,

Seoul 140-886, Korea
address 50, Irwon-Dong, Gangnam-Gu,Seoul,Korea 135-710
40
website
http://ctc.samsunghosital.com
tel
+82-2-3410-3695,3698
contact
Sung Hoon Jung
e-mail
sunghooni.jung@samsung.com
start-up year 1999
CEO
Han Yong Choi
employees 115
fax +82-2-3410-3699
website
http://www.scllab.co.kr
tel
fax
Headquaters; +82-2-790-6500, Central Lab.; +82-2-790-6011(ext.670)

Headquaters; +82-2-790-6509, Central Lab.; +82-2-790-6846
contact
Young Ja Lee (Chief Manager)
e-mail
yjlee@scllab.co.kr
start-up year 1983
CEO
Kyoung-Ryul Lee, M.D., Ph.D
employees 400
41
company name
Seoul Pharma Laboratories, Inc.
company profile
company name
Solomon Medical Research, Inc.
company profile
Seoul Pharma Laboratories(SPL) is a GLP-compliant drug

development partner focusing on responsiveness and
uncompromised quality. Core capabilities include PK/TK analysis,
Bioequivalence Test and Peptide Sequencing based on cutting edge
instrumentation such as UPLC, LC/MS/MS and Tof-MS.
As a leading CRO services provider in Korea, SPL has numerous
experiences of supporting our clients with individually tailored and
innovative analytical methods. Most importantly, dedicated SPL
employees are committed to deliver scientific excellence and
timeliness together to every project as promised.
Solomon Medical Research(SMR)s expertise in drug development

begins with Phase I trials through to Phase IV. SMR has worldwide
full-service capabilities, including Clinical Trial Management, Data
Management, Biostastical Analysis, Site Selection and Regulatory
Affairs. SMRs staffs comprise of personnels with a wealth of
experience in clinical trials for approval in the local market.
These highly trained and dedicated teams perform all-phase
clinical trials(Phase I, II, III and bridge trials) designed to obtain
approval, and post-marketing clinical trials.
business category
business category
42
contract research
clinical research
support services
non clinical
organization
contract research
clinical research
support services
non clinical
organization
address 3F, Daerung Techno Town ?327-32, Gasan-dong, Geumcheon-gu,

Seoul, Korea
address A-8F 906-5 Advanced Institte of Convergence Technolog, Iui-dong,

Youngtong-gu, Suwon city, Gyeonggi-do, Korea
website
www.splab.co.kr
website
www.solomonmed.com
tel
+82-2-866-5533
tel
+82-31-888-9250
contact
Bosung Ko
contact
Jihye Choi
e-mail
bsko@splab.co.kr
start-up year 2005
e-mail
smr@solomonmed.com
start-up year 2001
CEO
Hohyun Kim
employees 40
CEO
James Kim
employees 12
fax +82-2-868-5511
fax +82-31-888-9259
43
company name
World Courier Korea Co.,Ltd
company profile
company name
company profile
Established in 1969, World Courier is the global leader in the

transportation of clinical samples, investigational drugs and clinical
trial supplies, Infectious substances for the pharmaceutical
industry, with over 35years of experience in the handling of timecritical and temperature controlled shipments. We have handled
the logistics for thousands of clinical trials worldwide, we
understand intimately your timeline and demanding supply chain
requirements. World Courier has wholly owned global network
over 140 offices, 2,500 employees throughout the world.
YeBT has developed several diagnostic techniques for nucelic acid

amplified test (NAT). The rapid growth of the knowledge in OMICS
changes the basic paradigm of molecular diagnosis. Molecular
diagnosis with array system is the first priority in YeBT research
and development.
The current study of molecular diagnosis includes gene
translocations, identifying the Single Nucleotide Polymorphism,
virus genotyping, differential expression patterns of biomarkers.
Liquid bead array and microarray are employed for these projects.
Innovational technologies are developed for molecular diagnosis.
TotalPlex gene amplification, high yield labeling method are prime
examples. We believe their influences on molecular diagnosis will
be tremendous.
business category
44
YeBT
contract research
clinical research
support services
non clinical
organization
business category
contract research
clinical research
support services
non clinical
organization
address #621, DMC Hi-tech Industry Center, 1580, Sangam-dong, Mapo-gu,

Seoul, 121-270, Korea
address 1102-3 Happy World Dept. 917-6 Mok-dong, Yangchun-gu, Seoul, Korea
website
www.worldcourier.com
website
www.yebt.co.kr
tel
+82-2-6335-8538
tel
+82-2-747-9328
contact
Ms. Hee-Yang(Linda) Kim
contact
Boram Jung
e-mail
selops@worldcourier.co.kr
start-up year 2003
e-mail
info@yebt.net
start-up year 2006
CEO
Wayne Heyland
employees 18
CEO
Byoung Don Han
employees 5
fax +82-2-6335-8539
fax +82-2-747-9329
45
company name
Yonsei University Health System

Clinical Trials Center
company name
Young In Frontier Co., Ltd.
company profile
company profile
The clinical trials center of Severance Hospital, Yonsei University Health System has been
playing a pivotal role in clinical development of new drugs for domestic and multinational
pharmaceutical companies. As a part of Severance Hospital, we carry the same value and high
quality in clinical drug development as the hospital itself has its reputation in clinical practice,
research and patient care. Our primary concern and goal in conducting trials is to protect the
rights, safety and welfare of human subjects participating in studies. Based on international
medical care standards, numerous clinical investigators in the hospital and pharmacologists at
our center have closely collaborated for studies and care for participants. We provide services
throughout the whole process of clinical drug development such as planning and designing of
studies as well as analyzing and reporting of results. The center probably has the best
environment and technologies in Korea for early stage clinical trials as well as bioequivalence
studies. Especially, the 55 bed research ward is the biggest ward exclusively reserved for clinical
studies in Korea. For clinical trials in later stages, we do our best to assist the trials through our
active supporting system and prompt and clear administrative services. We are constantly
striving to become the best clinical trials center in Asia.
Young In Frontier Co., Ltd. is a leading antibody supplier in Korea in

terms not only of catalog & custom antibody, protein related
products and ELISA kits manufactured by our research center but
also in catering to the requirements of the researcher, doctors and
clinicians. This differentiates our organization from other
distributors and companies. Also we have been registered into
KOSDAQ (Korean Stock Market) since 1994 and # 1 Antibody
Company in Korea. In addition, we have served 6,000 antibody cases
per year for HUPO Global Human Protein Atlas as the largest
antibody project in the world since 2006 until 2014.
business category
business category
46
contract research
clinical research
support services
non clinical
organization
contract research
clinical research
support services
non clinical
organization
address 250, Seongsanro, Seodaemungu, Seoul, Republic of Korea (ZIP:120-752)
address 11F Byucksan Digital Valley 5th Gasan-dong, Guemcheon-gu Seoul

153-788 KOREA
website
sev.iseverance.com/ctc
website
http://www.abfrontier.com/
tel
+82-2-2228-0500
tel
+82-2-2140-3399
contact
JANG, Seokjin
contact
WOON JAE JUNG
e-mail
jangsj@yuhs.ac
start-up year
e-mail
orders@younginfrontier.com
start-up year 1994
CEO
Dr. PARK Minsoo
employees 40
CEO
Jong Seo Lee
employees 82
fax +82-2-392-0668
fax +82-2-2140-3320
47

Korea Lifescience Resource Guidebook2009

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Korea Lifescience Resource Guidebook2009

Uploaded by

Copyright:

Available Formats

KOREA,

The Gateway to ASIA

KOREA Life Science Services

KOREA Life Science Services

KOREA Life Science Services Resource Guide 2009

Korea Biotechnology Industry Organization

Information support and public relations

AJOU UNIVERSITY MEDICAL

address 9F., Unik Bldg, 706-13, Yeoksam-Dong, Kangnam-Gu Seoul, Republic

Non-profit organization Trade association

Contact1 InSuk(Lydia) Son, Assistant Manager

address San 5, Wonchun-dong, Yeongtong-gu, Suwon, Korea 443-721

Contact2 JongHoon Choi, Executive Director

start-up year 2005

AMC CRC (ASAN Medical Center Clinical

AnC Bio, Inc.

The AMC CRC is a top organization that makes patients and

address 86, Asanbyeongwon-gil, Songpa-gu, Seoul 138-736 Korea

address H.Q: 884-1 Eyon-ri, Cheongbuk-myon, Pyeongtaek, Gyeonggi, Korea

Seoul Office: +82-(0)2-549-7088

Seoul Office: +82-(0)2-549-7044

Sean Choi / Senior Manager / Medical Team

Jung-Shin Lee(Executive Director: Dongho Lee)

start-up year 1999

start-up year 2002

Our company has world-wide competitiveness in the development

BEAMS Biotechnology is one of the contract manufacturers for

BEAMS BIOTECHNOLOGY CO., LTD.

address 694-4 Sangchon, Jinsung, Jinju 660-852, South Korea

address B104 SuntechCity II, #307-2 Joongwon-ku, Sungnam, Kyoungki-Do,

CHEOL KIM, President / DOYUN KIM, Director

Dr. Yong Chul Shin

start-up year 2000

start-up year 2006

Dr. Yong Chul Shin

BIOTRION Co., Ltd.

Biotoxtech is a life science company and a Contract Research

BIOTRION is organized with experts who have more than 10 years

address Ochang science industrial complex, 686-2 Yangcheong-ri, Ochang-eup,

start-up year 2000

start-up year 1999

C&R Research Inc.

Chemizon is a collaborative drug discovery services organization

address 2/FI, Yiyangwon BD, 63-7 Gyeongun-dong, Jongno-gu, Seoul 110-310

address 3F 333-1, Sangdaewon-Dong, Jungwon-Gu, Seongnam-Si, GyeonggiDo, KOREA, 462-807

+82(0)2 6251 1500~3

start-up year 1997

start-up year 2005

fax +82(0)2 6251 1504

Chonbuk National University Hospital

address Gyeonggi Bio Research Center (Headquarter) 11F, Gyeonggi Bio

address 634-18, Geumam-dong, Deokjin-gu, Jeonju, 561-712, Republic of Korea

Ji-Young Jeon, Pharmacist

start-up year 2000

start-up year 2005

Soo-Wan Chae, M.D.,Ph.D.

Chonnam National University

CNUH CTC implements ethical and scientific clinical trials in

Chungnam National University Hospital Clinical Trials

Chungnam National University

address 671 Jebongno, Donggu, Gwangju, Korea (501-757)

address 33 Munhwa-ro, Jung-gu, Daejeon, 301-721, Korea

start-up year 2002

start-up year 2008